Navigation Links
Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
Date:10/24/2007

-Farber Cancer Institute in Boston.

"Survival rates among patients with unresectable locoregionally advanced squamous cell carcinoma have always been low. These data give these patients new reason for hope," said Jan B. Vermorken, MD, PhD, Head of Oncology Department, University Hospital Antwerp and Head of the EORTC section on Head and Neck Cancer and Principal Investigator of the EORTC 24971/TAX 323 study.

The approval by the U.S. Food and Drug Administration (FDA) and the positive opinion by the European Agency for the Evaluation of Medicinal products (EMEA) of the indications for Taxotere in combination with cisplatin and 5-fluorouracil for the induction treatment of patients with locally advanced SCCHN were based on the TAX 323 and TAX 324 study results.

About the Studies

Both studies are phase III, randomized, open-label trials that included patients with stage III or IV SCCHN with no distant metastases.

The TAX 323 study (EORTC 24971) enrolled 358 European patients with inoperable tumors. Patients were randomized to receive an infusion of Taxotere 75 mg/m2 plus cisplatin 75 mg/m2 on day one, and a five-day continuous infusion of fluorouracil 750 mg/m2 daily or intravenous cisplatin 100 mg/m2 on day one followed by five-day continuous infusion of fluorouracil 1000 mg/m2 per day. In both groups, treatment was given every three weeks for up to four cycles. Within four to seven weeks from the initiation of the last cycle of chemotherapy, both groups of patients were then given radiation therapy for seven weeks.

The Taxotere-based regimen demonstrated a significantly longer progression-free survival (the primary endpoint of the study). The updated survival analysis performed in 2005 at a median follow-up period of 51.1 months confirmed the survival benefit, demonstrating a 4.3 month higher median overall survival for patients receiving the Taxotere-based regimen than for those receiving the standard chemotherapy (without Taxoter
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28 de agosto de 2015   Royal ... participación en el  Congreso de la ESC de ... recientes y novedosas, entre ellas HeartModel A.I.  , ... personas y la tecnología con los protocolos de ... los tratamientos y permitir atención en el hogar. ...
(Date:8/27/2015)... 2015 DURECT Corporation (Nasdaq: DRRX ) ... three upcoming healthcare conferences.  , ... at the Rodman & Renshaw Investment Conference on Thursday, ... is being held at the St. Regis Hotel in ... audio webcast of the presentation will be available by ...
(Date:8/27/2015)... 27, 2015  Now that Intuitive Surgical, Inc.® has ... surgical robot, hospitals with robotic surgery programs need to ... to see where they stand with robotic surgery. Are ... Have they adopted best practices for safety? Should they ... future? ECRI Institute, which has nearly 50 ...
Breaking Medicine Technology:Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3
... CAMBRIDGE, Mass., March 18 Peptimmune, Inc. a ... its first,clinical trial to evaluate the safety, tolerability, ... for the treatment of,multiple sclerosis and other autoimmune ... double blind placebo controlled,randomized study involved 56 healthy ...
... of Pennsylvania shows promising results, ATLANTA, March ... increase milk production of dairy cows. A study ... School of,Veterinary Medicine (Penn Vet) indicates that improving ... has the potential to,produce the desired results., ...
Cached Medicine Technology:Peptimmune Completes Phase I Study with a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 3Increasing Dairy Milk Production with Electrolyzed Drinking Water 4Increasing Dairy Milk Production with Electrolyzed Drinking Water 5
(Date:8/28/2015)... ... August 28, 2015 , ... Joining ... County Memorial Hospital recently transitioned management companies to partner with Wound Care Advantage ... their outpatient wound center. , Transitioning wound care management providers can be ...
(Date:8/28/2015)... Port Richey, FL (PRWEB) , ... August 28, 2015 , ... ... while many potential workers are qualified for the position they are applying for, they ... Because of this, many employers are considering altering drug testing policies in order to ...
(Date:8/28/2015)... Dallas, TX (PRWEB) , ... August 28, 2015 , ... ... Surgical Center is taking part with their subsidiary USPI Tenet Health. , The American ... to fight heart disease and stroke. They believe that together, a difference can be ...
(Date:8/28/2015)... ... ... The 6th Annual Survivor in the City, Chicago silent auction and ... to its cadre of widespread support—an official letter of support and gratitude from the ... community and the University of Illinois at Chicago’s Department of Neurosurgery, the Brain Aneurysm ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... 20 grams of high grade protein with zero fat, carbs, sugar, gluten, lactose ... been named a finalist for the 2015 SupplySide CPG Editor’s Choice Awards. , ...
Breaking Medicine News(10 mins):Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3
... will discuss preclinical drug discovery and development at SUNY ... presentation will take place at 12:00 noon in the ... Lenox Road, Brooklyn, New York 11203. Dr. ... and modified to become "Lead" compounds in the high-risk ...
... DURHAM, N.H. Runners over the age of 60 are the ... of New Hampshire suggests that their running can remain fast as ... of Strength and Conditioning Research , found that the running economy ... of older runners was no different than that of younger ...
... , TUESDAY, Nov. 29 (HealthDay News) -- A new report ... backs, raising the risk of temporary head-flattening. In general, ... away on their own, but doctors should be on the ... aware that they can prevent flattened heads on one side ...
... history of breast cancer are just as likely to develop ... of the disease, according to a study presented today at ... (RSNA). These findings indicate that women in this age group ... cancer screening guidelines issued by the U.S. Preventive Services Task ...
... Orleans, LA Research led by Dr. Paul Harch, ... Center New Orleans, has found that treatment with hyperbaric ... and quality of life for veterans with traumatic brain ... online now in the Journal of Neurotrauma . ...
... Department of Radiology at NYU Langone Medical Center will ... 97th Scientific Assembly and Annual Meeting of the Radiology ... - December 2, 2011. Experts are available to comment ... and its application for specific conditions. Presentations include: ...
Cached Medicine News:Health News:Dr. Luther T. Clark to present Merck Academy Talk at SUNY Downstate 2Health News:Study: No decline in running economy for older runners 2Health News:'Flat Head' Syndrome in Babies Usually Temporary 2Health News:'Flat Head' Syndrome in Babies Usually Temporary 3Health News:New study supports mammography screening at 40 2Health News:LSUHSC research shows Rx with hyperbaric oxygen improved TBI and PTSD in vets 2Health News:NYU Langone experts present at annual meeting of Radiological Society of North America 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: